A Dark Vector Cognition product

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

3K characters. Original on sec.gov ·

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

The following table sets forth information with respect to the Company's repurchases of common stock during the quarter ended July 31, 2026:

PeriodTotal Number of Shares PurchasedAverage Price Paid Per ShareTotal Number of Shares Purchased as Part of Publicly Announced Plans or ProgramsMaximum Dollar Value of Shares That May Yet Be Purchased Under the Plans or Programs
First Quarter
May 1 - May 31, 202618,696$842.0618,696$78,868,744
June 1 - June 30, 202617,386814.8217,386988,332,112
July 1 - July 31, 202618,565847.3518,565972,601,128
Total54,647$835.1954,647$972,601,128

On, and effective as of, March 3, 2022, the Board authorized a share repurchase program, whereby the Company was authorized to repurchase its outstanding common stock from time-to-time, for an aggregate amount of up to $400 million, exclusive of fees, commissions, excise taxes, or other costs (the "Original Repurchase Program"). On, and effective as of, June 4, 2026, the Board of Directors authorized an expansion of the Original Repurchase Program to a total aggregate amount of up to $1.0 billion exclusive of fees, commissions, excise taxes, or other costs (the "Expanded Repurchase Program"). The Expanded Repurchase Program has no set expiration date. The timing and number of repurchase transactions under the Expanded Repurchase Program depends on a variety of factors including, but not limited to, market conditions, corporate considerations, business opportunities, debt agreements, and regulatory requirements. The Expanded Repurchase Program can be suspended or discontinued at any time. During the first quarter, we repurchased and retired 54,647 shares of our common stock under the share repurchase programs for a total of $45.6 million, excluding fees, commissions, excise taxes, and other costs. As of July 31, 2026, $972.6 million remained available thereunder.

Table of Contents

Previous: Item 1A. Risk Factors · Next: Item 6. Exhibits.